Ticker Details
Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$4.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 2.96%
Avg Daily Range (30 D):	$2.10 | 2.00%
Avg Daily Range (90 D):	$2.17 | 2.87%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.82M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	803
Avg Institutional Trade:	$3.41M
Avg Institutional Trade (30 D):	$8.61M
Avg Institutional Trade (90 D):	$4.84M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.85M
Avg Closing Trade (30 D):	$15.85M
Avg Closing Trade (90 D):	$9.63M
Avg Closing Volume:	127.91K

News

Dec 4, 2025 @ 9:47 AM 3 Stocks You’ll Wish You Bought Before 2026... Source: Chris Markoch

Nov 27, 2025 @ 10:22 PM This Fund Bought $38 Million of Celcuity as Stock ... Source: Jonathan Ponciano

Oct 18, 2025 @ 8:30 AM Detailed Results from PIK3CA Wild-Type Cohort o... Source: Celcuity Inc.

Oct 18, 2025 @ 8:30 AM Celcuity Presents Updated Data at the 2025 ESMO Co... Source: Celcuity Inc.

Oct 18, 2025 @ 8:30 AM Celcuity Provides Update on Status of the PIK3CA M... Source: Brian Sullivan

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.69	$-.92	$-1.04
Diluted EPS	$-3.68	$-.92	$-1.04
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-162.72M	$-43.8M	$-45.27M
Operating Income / Loss	$-159.42M	$-42.85M	$-44.01M
Cost of Revenue
Net Cash Flow	$61.65M	$27.9M	$29.88M
PE Ratio